JP2008523140A5 - - Google Patents

Download PDF

Info

Publication number
JP2008523140A5
JP2008523140A5 JP2007546603A JP2007546603A JP2008523140A5 JP 2008523140 A5 JP2008523140 A5 JP 2008523140A5 JP 2007546603 A JP2007546603 A JP 2007546603A JP 2007546603 A JP2007546603 A JP 2007546603A JP 2008523140 A5 JP2008523140 A5 JP 2008523140A5
Authority
JP
Japan
Prior art keywords
separation matrix
matrix according
particles
binding protein
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007546603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008523140A (ja
JP5787461B2 (ja
Filing date
Publication date
Priority claimed from SE0403057A external-priority patent/SE0403057D0/sv
Application filed filed Critical
Priority claimed from PCT/SE2005/001900 external-priority patent/WO2006065208A1/en
Publication of JP2008523140A publication Critical patent/JP2008523140A/ja
Publication of JP2008523140A5 publication Critical patent/JP2008523140A5/ja
Application granted granted Critical
Publication of JP5787461B2 publication Critical patent/JP5787461B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007546603A 2004-12-14 2005-12-12 免疫グロブリンの精製方法 Expired - Lifetime JP5787461B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0403057-3 2004-12-14
SE0403057A SE0403057D0 (sv) 2004-12-14 2004-12-14 Purification of immunoglobulins
US63831604P 2004-12-22 2004-12-22
US60/638,316 2004-12-22
PCT/SE2005/001900 WO2006065208A1 (en) 2004-12-14 2005-12-12 Purification of immunoglobulins

Publications (3)

Publication Number Publication Date
JP2008523140A JP2008523140A (ja) 2008-07-03
JP2008523140A5 true JP2008523140A5 (enExample) 2008-12-11
JP5787461B2 JP5787461B2 (ja) 2015-09-30

Family

ID=36588164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007546603A Expired - Lifetime JP5787461B2 (ja) 2004-12-14 2005-12-12 免疫グロブリンの精製方法

Country Status (5)

Country Link
EP (1) EP1830947A4 (enExample)
JP (1) JP5787461B2 (enExample)
AU (1) AU2005317279C1 (enExample)
CA (1) CA2586803C (enExample)
WO (1) WO2006065208A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5620626B2 (ja) 2005-03-31 2014-11-05 中外製薬株式会社 会合制御によるポリペプチド製造方法
DK2006381T3 (en) 2006-03-31 2016-02-22 Chugai Pharmaceutical Co Ltd PROCEDURE FOR REGULATING ANTIBODIES BLOOD PHARMACOKINETICS
EP2009101B1 (en) 2006-03-31 2017-10-25 Chugai Seiyaku Kabushiki Kaisha Antibody modification method for purifying bispecific antibody
JP5345539B2 (ja) * 2006-09-29 2013-11-20 ジーイー・ヘルスケア・バイオ−サイエンシズ・アーベー 抗体単離のためのスタフィロコッカスアウレウス由来のドメインｃを含むクロマトグラフィーリガンド
SG149759A1 (en) * 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
ES2687808T3 (es) 2007-09-26 2018-10-29 Chugai Seiyaku Kabushiki Kaisha Región constante de anticuerpo modificado
DK2202245T3 (en) 2007-09-26 2016-11-21 Chugai Pharmaceutical Co Ltd A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR
US8277649B2 (en) * 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
EP2543730B1 (en) 2010-03-04 2018-10-31 Chugai Seiyaku Kabushiki Kaisha Antibody constant region variant
CA2791918C (en) 2010-03-05 2019-11-19 Boehringer Ingelheim International Gmbh Selective enrichment of antibodies
CN102388061A (zh) * 2010-03-17 2012-03-21 松下电器产业株式会社 将由a蛋白或a蛋白的a至e结构域中的至少一个结构域所组成的蛋白质结合到基材上的方法
US8859294B2 (en) 2010-03-17 2014-10-14 Panasonic Corporation Method for binding a protein consisting of protein A or consisting of at least one domain of the A to E domains of the protein A to the substrate
US9090665B2 (en) 2010-03-31 2015-07-28 Jsr Corporation Filler for affinity chromatography
JP5998050B2 (ja) 2010-03-31 2016-09-28 Jsr株式会社 アフィニティークロマトグラフィー用充填剤
TR201802772T4 (tr) 2010-11-17 2018-03-21 Chugai Pharmaceutical Co Ltd Kan pıhtılaşma faktörü VIII in işlevi için alternatif işleve sahip multi-spesifik antijen bağlayıcı molekül.
LT2647707T (lt) 2010-11-30 2018-11-12 Chugai Seiyaku Kabushiki Kaisha Citotoksiškumą indukuojantis terapinis agentas
WO2015030094A1 (ja) 2013-08-30 2015-03-05 株式会社カネカ Ｆａｂ領域結合性ペプチド
WO2015035076A1 (en) * 2013-09-04 2015-03-12 Sten Ohlson Weak affinity chromatography
JP6230853B2 (ja) * 2013-09-06 2017-11-15 株式会社日立製作所 タンパク質の精製方法及び精製装置
ES2881306T3 (es) 2013-09-27 2021-11-29 Chugai Pharmaceutical Co Ltd Método para la producción de heteromultímeros de polipéptidos
US20170043320A1 (en) 2013-11-27 2017-02-16 Jsr Corporation Solid-phase carrier, production method for solid-phase carrier, carrier for affinity refining, production method for filler for affinity chromatography, filler for affinity chromatography, chromatography column, and refining method
EP3094391B1 (en) 2014-01-17 2024-11-20 Repligen Corporation Sterilizing chromatography columns
CN119751653A (zh) 2014-06-24 2025-04-04 思拓凡生物工艺研发有限公司 层析方法
KR102410991B1 (ko) 2014-06-27 2022-06-17 제이에스알 가부시끼가이샤 친화성 크로마토그래피용 담체
US20170334947A1 (en) * 2014-08-28 2017-11-23 Kaneka Corporation Affinity separation matrix for fab region-containing peptide
JPWO2016121701A1 (ja) 2015-01-26 2017-11-09 株式会社カネカ 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス
JP6663360B2 (ja) 2015-01-26 2020-03-11 株式会社カネカ 変異型免疫グロブリンκ鎖可変領域結合性ペプチド
WO2016159213A1 (ja) 2015-04-01 2016-10-06 中外製薬株式会社 ポリペプチド異種多量体の製造方法
JP7219005B2 (ja) * 2015-12-28 2023-02-07 中外製薬株式会社 Ｆｃ領域含有ポリペプチドの精製を効率化するための方法
JP7320943B2 (ja) 2016-04-28 2023-08-04 中外製薬株式会社 抗体含有製剤
WO2017195638A1 (ja) 2016-05-09 2017-11-16 株式会社カネカ 抗体またはκ鎖可変領域含有抗体断片の精製方法
WO2017195641A1 (ja) * 2016-05-11 2017-11-16 株式会社カネカ アフィニティ分離マトリックスの製造方法およびアフィニティ分離マトリックス
GB201703116D0 (en) * 2017-02-27 2017-04-12 Ge Healthcare Bioprocess R&D Ab A seperation matrix and a method of seperating antibodies
AU2018361430B2 (en) 2017-11-01 2025-08-14 Chugai Seiyaku Kabushiki Kaisha Antibody variant and isoform with lowered biological activity

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US5089605A (en) * 1987-03-13 1992-02-18 Repligen Corporation Immobilized immunoglobulin-binding proteins
US5445732A (en) * 1992-06-19 1995-08-29 Sepracor Inc. Passivated porous polymer supports and methods for the preparation and use of same
WO1994022918A1 (en) * 1993-03-29 1994-10-13 Minnesota Mining And Manufacturing Company Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof
SE9503925D0 (sv) * 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separationsmedium för IgG
SE9601368D0 (sv) * 1996-04-11 1996-04-11 Pharmacia Biotech Ab Process for the production of a porous cross-linked polysaccharide gel
US6599620B2 (en) * 1997-01-07 2003-07-29 Kaneka Corporation Cellulosic particles, spherical object comprising cross-linked polymer particles, and adsorbent for body fluid purification
SE9700383D0 (sv) * 1997-02-04 1997-02-04 Pharmacia Biotech Ab An adsorption/separation method and a medium for adsorption/separation
SE0004929D0 (sv) * 2000-12-29 2000-12-29 Apbiotech Ab A method for producing liquid chromatography matrices
SE0200943D0 (sv) * 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
SE0300482D0 (sv) * 2003-02-21 2003-02-21 Amersham Biosciences Ab Inorganic beads with hierarchical pore structures
US7700743B2 (en) * 2003-07-22 2010-04-20 Millipore Corporation Immobilised affinity medium and its use in separation
WO2006024497A1 (en) * 2004-08-30 2006-03-09 Lonza Biologics Plc. Affinity- plus ion exchange- chromatography for purifying antibodies

Similar Documents

Publication Publication Date Title
JP2008523140A5 (enExample)
Kumar et al. Affinity fractionation of lymphocytes using a monolithic cryogel
Ertürk et al. Cryogels-versatile tools in bioseparation
Purtov et al. Nanodiamonds as carriers for address delivery of biologically active substances
Dainiak et al. Detachment of affinity-captured bioparticles by elastic deformation of a macroporous hydrogel
Zhang et al. Crystal-size-dependent structural transitions in nanoporous crystals: adsorption-induced transitions in ZIF-8
Gooding et al. HPLC of Biological Macro-Molecules, revised and expanded
EP2166018A3 (en) Antibody binding affinity ligands
Salimi et al. Protein A and protein A/G coupled magnetic SiO2 microspheres for affinity purification of immunoglobulin G
JP2013507237A5 (enExample)
JP2002531090A5 (enExample)
Mhemeed A general overview on the adsorption
AU6267000A (en) Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
JP2010534336A5 (enExample)
Gustavsson et al. Superporous agarose as an affinity chromatography support
Akkaya et al. Concanavalin A immobilized magnetic poly (glycidyl methacrylate) beads for antibody purification
Soares et al. Molecular imprinting of β-cyclodextrin/cholesterol template into a silica polymer for cholesterol separation
SE0403057D0 (sv) Purification of immunoglobulins
WO2001034292A3 (en) Macroporous media for biological application prepared by freeze drying
Seo et al. A Three‐Dimensional Nanostructured Array of Protein Nanoparticles
Du et al. Highly porous polymer monolith immobilized with aptamer (RNA) anchored grafted tentacles and its potential for the purification of lysozyme
Thipe et al. Hybrid nanomaterials for detection, detoxification, and management mycotoxins
JP2003520214A5 (enExample)
Öztürk et al. Preparation of poly (2‐hydroxyethyl methacrylate)‐grafted chitosan‐montmorillonite superabsorbent nanocomposite for adsorption of bovine serum albumin
Lasich et al. Adsorption of humid air in compacted montmorillonite: A Monte Carlo simulation study